Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Gains from Sales and Divestitures (2018 - 2025)

Mesa Laboratories' Gains from Sales and Divestitures history spans 8 years, with the latest figure at $16.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 33.33% to $16.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $16.0, a 33.33% increase, with the full-year FY2025 number at $12000.0, down 57.14% from a year prior.
  • Gains from Sales and Divestitures hit $16.0 in Q4 2025 for Mesa Laboratories, up from $4.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for MLAB hit a ceiling of $29000.0 in Q1 2022 and a floor of $4.0 in Q2 2025.
  • Historically, Gains from Sales and Divestitures has averaged $6608.1 across 5 years, with a median of $28.0 in 2021.
  • Biggest five-year swings in Gains from Sales and Divestitures: tumbled 99.81% in 2023 and later skyrocketed 180.0% in 2024.
  • Tracing MLAB's Gains from Sales and Divestitures over 5 years: stood at $28.0 in 2021, then fell by 7.14% to $26.0 in 2022, then dropped by 3.85% to $25.0 in 2023, then tumbled by 52.0% to $12.0 in 2024, then soared by 33.33% to $16.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for MLAB at $16.0 in Q4 2025, $4.0 in Q3 2025, and $4.0 in Q2 2025.